Bioliquid is a biomedical technology-based company that focuses on women's and fetal health. Our objective is to develop new tools to isolate fetal and tumor cells from a liquid biopsy, with the vision to improve non-invasive prenatal tests and prognostic, treatment, and monitorization of gynecological diseases.